Detalles de la búsqueda
1.
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.
Br J Clin Pharmacol
; 73(5): 821-5, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22044433
2.
Ocriplasmin for treatment of vitreomacular traction and macular hole: A systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials.
Surv Ophthalmol
; 67(3): 697-711, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480895
3.
Effectiveness of ocriplasmin in real-world settings: A systematic literature review, meta-analysis, and comparison with randomized trials.
Acta Ophthalmol
; 99(6): e823-e836, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33369248
4.
Metabolic effects of a growth hormone-releasing factor in patients with HIV.
N Engl J Med
; 357(23): 2359-70, 2007 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-18057338
5.
Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature.
Patient Relat Outcome Meas
; 10: 101-116, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30988647
6.
A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial.
Patient Relat Outcome Meas
; 10: 335-343, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31754316
7.
Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs.
Br J Clin Pharmacol
; 74(1): 209-10, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22242895
Resultados
1 -
7
de 7
1
Próxima >
>>